Caroline Carpenter
Family · Saint Joseph, LANPI 1023321601
Payments from drug & device makers
Across 51 payments — averaging $54.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Esperion Therapeutics, Inc.$626
- AstraZeneca$266
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$247
- Novo Nordisk$209
- Bayer$205
- Mayne Pharma Commercial LLC$151
- plus $1K from 15 others
What the payments were for
- Consulting fees$1004%
- Food & beverage$2,70496%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Esperion Therapeutics, Inc. | 6 | $626 |
| AstraZeneca(2 entities) | 7 | $266 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $247 |
| Novo Nordisk | 7 | $209 |
| Bayer | 4 | $205 |
| Mayne Pharma Commercial LLC | 2 | $151 |
| Johnson & Johnson | 2 | $127 |
| Otsuka America Pharmaceutical, Inc. | 1 | $124 |
| Lilly USA, LLC | 3 | $123 |
| Activ Surgical, Inc. | 1 | $100 |
| AbbVie | 2 | $94 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $94 |
| Evofem Biosciences, Inc. | 3 | $79 |
| Axsome Therapeutics, Inc. | 1 | $79 |
| Viiv Healthcare Company | 1 | $75 |
| Gilead | 1 | $68 |
| Sumitomo Pharma America, Inc. | 1 | $55 |
| Amarin Pharma, Inc. | 2 | $36 |
| Exact Sciences | 1 | $17 |
| Boehringer Ingelheim | 1 | $15 |
| Avanir Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NEXLIZET$374
- NEXLETOL$374
- CAPLYTA$233
- NEXTSTELLIS$125
- REXULTI$124
- Wegovy$113
- FARXIGA$104
- ActivSight$100
How this compares
$2,804 in reported general payments places this provider in the 80th percentile of 3,610 family providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 35 | $523 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 17 | $309 |
| Simvastatin | 15 | $308 |
| Lisinopril | 26 | $282 |
| Levothyroxine Sodium | 18 | $277 |
| Losartan Potassium | 24 | $249 |
| Rosuvastatin Calcium | 18 | $231 |
| Amlodipine Besylate | 36 | $214 |
| Atenolol | 13 | $208 |
| Atorvastatin Calcium | 34 | $204 |
| Metoprolol Tartrate | 11 | $191 |
| Azithromycin | 49 | $156 |
| Metoprolol Succinate | 13 | $149 |
| Fluticasone Propionate | 21 | $140 |
| Meloxicam | 16 | $130 |
Paid to pharmacies, not to this prescriber.
Other family in Saint Joseph
- Rebecca EzellSlidell$268K
- Erin PierceNew Orleans$261K
- Tavell KindallNew Orleans$194K
- Ashlea HillRuston$169K
- Brittany MillerVille Platte$158K
- Ryanne ClarkeGretna$123K
- Elidia DewittBaton Rouge$108K
- Rebekah GarrardLafayette$105K
- Tiffany RoeShreveport$97K
- Ghenet GhebretatiosBaton Rouge$91K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.